Видео ютуба по тегу Pascal Soriot

Bloomberg Turnaround - Episode 3 - AstraZeneca | Pascal Soriot’s Bold Pharma Strategy
Bloomberg Turnaround - Episode 3 - AstraZeneca | Pascal Soriot’s Bold Pharma Strategy
AstraZeneca bets BIG on US with MASSIVE investment
AstraZeneca bets BIG on US with MASSIVE investment
AstraZeneca CEO Pascal Soriot on its plan to invest $50 billion in the U.S.
AstraZeneca CEO Pascal Soriot on its plan to invest $50 billion in the U.S.
AstraZeneca's US Investment, Future of Psychedelic Therapy | Bloomberg Businessweek Daily 7/29/2025
AstraZeneca's US Investment, Future of Psychedelic Therapy | Bloomberg Businessweek Daily 7/29/2025
AstraZeneca's US Investment, Future of Psychedelic Therapy | Bloomberg Businessweek Daily 7/29/2025
AstraZeneca's US Investment, Future of Psychedelic Therapy | Bloomberg Businessweek Daily 7/29/2025
AstraZeneca CEO Talks Drug Sales in US | Bloomberg Talks
AstraZeneca CEO Talks Drug Sales in US | Bloomberg Talks
AstraZeneca Profit, Revenue Lifted by Cancer Drugs: CEO Interview
AstraZeneca Profit, Revenue Lifted by Cancer Drugs: CEO Interview
AstraZeneca CEO: If you manufacture locally, there's no need to increase prices
AstraZeneca CEO: If you manufacture locally, there's no need to increase prices
AstraZeneca CEO on US Importance Amidst Trump Tariffs
AstraZeneca CEO on US Importance Amidst Trump Tariffs
AstraZeneca's $50 BILLION US Bet! Listing Shift?
AstraZeneca's $50 BILLION US Bet! Listing Shift?
Investing $50 Billion in US Manufacturing and R&D by 2030
Investing $50 Billion in US Manufacturing and R&D by 2030
Drug maker AstraZeneca to expand its manufacturing in US
Drug maker AstraZeneca to expand its manufacturing in US
AstraZeneca CEO: We totally agree with President Trump on this
AstraZeneca CEO: We totally agree with President Trump on this
AstraZeneca CEO on breast cancer drug trial: This is the future of cancer treatment
AstraZeneca CEO on breast cancer drug trial: This is the future of cancer treatment
AstraZeneca (AZN) Q1 2025 Earnings – Full Coverage
AstraZeneca (AZN) Q1 2025 Earnings – Full Coverage
Chez AstraZeneca, la revanche du Français Pascal Soriot
Chez AstraZeneca, la revanche du Français Pascal Soriot
AstraZeneca has built resilient supply chains in U.S., China: CEO
AstraZeneca has built resilient supply chains in U.S., China: CEO
AstraZeneca CEO talks tariffs, first quarter earnings
AstraZeneca CEO talks tariffs, first quarter earnings
AstraZeneca CEO: China already a global innovation hub
AstraZeneca CEO: China already a global innovation hub
Beijing Night•RECEPTION OF CHINA DEVELOPMENT FORUM 2025 AstraZeneca plc. Sir Pascal Soriot阿斯利康苏博科爵士
Beijing Night•RECEPTION OF CHINA DEVELOPMENT FORUM 2025 AstraZeneca plc. Sir Pascal Soriot阿斯利康苏博科爵士